SYMPATHOADRENAL SYSTEM ACTIVITY AND THE RISK OF ARRHYTHMIA DEVELOPMENT IN PATIENTS WITH ISCHEMIC HEART DISEASE

Authors

  • Kholmirzayev S.A., Mahamadumarov K. Impulse Medical Institute Teacher of the Department of Pathology and Microbiology Impulse Medical Institute Teacher of the Department of Morphology Author

Keywords:

sympathoadrenal system, catecholamines, CaMKII, delayed afterdepolarization, electrical instability, ventricular arrhythmia, heart rate variability, oxidative stress.

Abstract

 Ischemic heart disease (IHD) remains one of the leading causes of cardiovascular morbidity and mortality worldwide. Among its most dangerous complications are ventricular arrhythmias, sudden cardiac death, heart failure, and recurrent hospitalization. In recent years, it has become clear that arrhythmogenesis in IHD cannot be explained only by coronary stenosis, myocardial scarring, or reduced left ventricular ejection fraction. Myocardial ischemia activates the sympathoadrenal system, increases catecholamine release, enhances β-adrenergic signaling, disrupts intracellular calcium handling, and promotes oxidative stress. Calcium/calmodulin-dependent protein kinase II (CaMKII) is considered a key molecular mediator in this process. By modulating ryanodine receptors, L-type Ca²⁺ channels, the phospholamban/SERCA system, and Naᵥ1.5 sodium channels, CaMKII promotes diastolic Ca²⁺ leak, delayed afterdepolarization, action potential duration dispersion, and myocardial electrical instability. This review analyzes the relationship between sympathoadrenal activation and arrhythmia risk in patients with IHD through CaMKII-dependent mechanisms, delayed afterdepolarization, and electrical instability.

References

1.Vrints C., Andreotti F., Koskinas K.C., Rossello X., Adamo M., Ainslie J. et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal. 2024;45(36):3415-3537. doi:10.1093/eurheartj/ehae177.

2.Zeppenfeld K., Tfelt-Hansen J., de Riva M., Winkel B.G., Behr E.R., Blom N.A. et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal. 2022;43(40):3997-4126. doi:10.1093/eurheartj/ehac262.

3.Herring N., Kalla M., Paterson D.J. The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies. Nature Reviews Cardiology. 2019;16(12):707-726. doi:10.1038/s41569-019-0221-2.

4.Zekios K.C., Mouchtouri E.T., Kolettis T.M. Sympathetic Activation and Arrhythmogenesis after Myocardial Infarction: Where Do We Stand? Journal of Cardiovascular Development and Disease. 2021;8(5):57. doi:10.3390/jcdd8050057.

5.Bell J.R., Vila-Petroff M., Delbridge L.M.D. CaMKII-dependent responses to ischemia and reperfusion challenges in the heart. Frontiers in Pharmacology. 2014;5:96. doi:10.3389/fphar.2014.00096.

6.Howard T., Greer-Short A., Satroplus T., Patel N., Nassal D., Mohler P.J., Hund T.J. CaMKII-dependent late Na⁺ current increases electrical dispersion and arrhythmia in ischemia-reperfusion. American Journal of Physiology-Heart and Circulatory Physiology. 2018;315(4):H794-H801. doi:10.1152/ajpheart.00197.2018.

7.Hansen M.H., Sadredini M., Hasic A., Anderson M.E., Sjaastad I., Stokke M.K. CaMKII and reactive oxygen species contribute to early reperfusion arrhythmias, but oxidation of CaMKIIδ at methionines 281/282 is not a determining factor. Journal of Molecular and Cellular Cardiology. 2023;175:49-61. doi:10.1016/j.yjmcc.2022.12.002.

8.La Rovere M.T., Bigger J.T. Jr., Marcus F.I., Mortara A., Schwartz P.J.; ATRAMI Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. The Lancet. 1998;351(9101):478-484. doi:10.1016/S0140-6736(97)11144-8.

9.Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043-1065. PMID:8598068.

10.Luo M., Guan X., Luczak E.D., Lang D., Kutschke W., Gao Z. et al. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. Journal of Clinical Investigation. 2013;123(3):1262-1274. doi:10.1172/JCI65268.

Downloads

Published

2026-06-09